Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Spondylitis, Ankylosing 1Psoriasis 1Osteosarcoma 1Neuroblastoma 1Lung Neoplasms 1Crohn Disease 1Chickenpox 1Arthritis, Rheumatoid 1Arthritis, Psoriatic 1Arthritis 1

Interventions

Educational Status 2vedolizumab 1Vitamin E 1Vaccines 1Sutures 1Surveys and Questionnaires 1Surgical Instruments 1Standard of Care 1Soybean Oil 1Saline Solution 1Ringer's Lactate 1Proctocolectomy, Restorative 1Practice Guidelines as Topic 1Pneumococcal Vaccines 1Photoplethysmography 1Phlebotomy 1Papillomavirus Vaccines 1Nivolumab 1Methods 1Lysine Acetyltransferase 5 1Laparoscopy 1Iron-Dextran Complex 1Interviews as Topic 1Infliximab 1Indigo Carmine 1Hydroxyethyl Starch Derivatives 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Herpes Zoster Vaccine 1Fish Oils 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Crohn Disease × Herpes Zoster Vaccine × Clear all
NCT02538341 2021-11-23

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

University of Alabama at Birmingham

Phase 2 Completed
617 enrolled 17 charts

Arthritis, Arthritis, Rheumatoid, Crohn Disease, Psoriasis, Spondylitis, Ankylosing, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡